IONS vs NDRA · rev $226.6M vs P/E 0.0, $2.6M cap
Ionis Pharmaceuticals Inc (IONS) versus ENDRA Life Sciences Inc (NDRA) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
ENDRA Life Sciences Inc (NDRA) is a diagnostics & research company listed on US.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
NDRA does not have a complete income-statement cache yet.
IONS currently screens at market cap $12.28B. NDRA currently screens at market cap $2.6M and trailing P/E 0.0.
Not investment advice. Open the IONS and NDRA stock pages for the full models.
Not investment advice.